Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04276948 · ClinicalTrials.gov registry record · NA
Effects of NAD3 Supplementation on Biomarkers of Aging
A NA study, sponsored by The Center for Applied Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT04276948 is a NA study that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 45 participants.
The verdict
NCT04276948, a NA study, has completed, sponsored by The Center for Applied Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This is a randomized, parallel-group, placebo-controlled, clinical trial in middle-aged and older male and female subjects from Ohio. Subjects will take an over-the-counter dietary supplement or a placebo for 12 weeks. Outcome measures will include body weight, systolic and diastolic blood pressure, standard blood chemistries (e.g. chemistry panel, lipid panel, CBC with differential), changes in mood, vitality, energy, fatigue, productivity, digestive wellness (via anchored Visual Analogue Scales).
Interventions
- DIETARY_SUPPLEMENT NAD3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-06-08 |
| Est. Completion | 2021-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04276948
The ClinicalTrials.gov registry entry for NCT04276948 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Center for Applied Health Sciences, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NAD3 is the first listed.
NCT04276948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04276948 about?
NCT04276948 is a clinical study titled "Effects of NAD3 Supplementation on Biomarkers of Aging". This is a randomized, parallel-group, placebo-controlled, clinical trial in middle-aged and older male and female subjects from Ohio. Subjects will take an over-the-counter dietary supplement or a placebo for 12 weeks. Outcome measures will include body weight, systolic and diastolic blood pressure,...
What is the current status of trial NCT04276948?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2020-06-08. Estimated completion is 2021-05-30.
What interventions are being tested in trial NCT04276948?
The interventions under investigation include: NAD3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04276948?
This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.